A comprehensive view of Diabetes. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Eli Lilly and Company Files Taiwan Patent Application for Long-Acting Amylin Receptor Agonists and Uses Thereof

Eli Lilly and Company Submits Patent Application for Incretin Analog-Containing Compositions and Uses Thereof

High demand for injectable weight-loss drugs has led to supply issues, with most varieties listed in short supply by the FDA; Eli Lilly reports shortages of its Zepbound and Mounjaro could last until 2025

Nestle SA Gets Patent for Compositions Comprising Citrulline and Leucine and Their Use in the Treatment of Diabetes and Metabolic Syndrome

Eli Lilly and plaintiffs abandon proposed US$13.5M settlement regarding alleged overpricing of insulin; the move follows a court ruling against certifying specific state-classes in the case

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count